A prospective feasibility study on extreme hypofractionation in adjuvant radiation of breast cancer in a tertiary cancer center in India

INTRODUCTION: Breast cancer is the most common cancer among women in India at present, having overtaken cancer cervix. Treatment of breast cancer is a multimodality approach. Adjuvant radiation therapy plays a major role in the treatment of breast cancer. Standard of care in adjuvant therapy changed...

Full description

Bibliographic Details
Published in:	Annals of Oncology Research and Therapy
Main Authors:	Sri Sai Tejaswini Muddana, Vijay Anand Reddy Palkonda, Madhuri Kavikondala, Prashant Upadhyaya, Vijay Karan Reddy, Shilpa Reddy Keesara, Karthik Pathri, Shravanthi Reddy Bussyaku, Padma Ganesan, P. Sathish Kumar, R. Rajasekaran, Delhi Babu Mohan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Subjects:	breast hypofractionation radiation therapy
Online Access:	https://journals.lww.com/10.4103/aort.aort_48_24

Similar Items

Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy
by: Ahmed Magdy, et al.
Published: (2025-05-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Efficacy and Toxicity of Hypofractionated Palliative Radiotherapy for Breast Cancer Patients with Skin Invasion
by: Talha Maqsood, et al.
Published: (2023-08-01)

Weekly ultra-hypofractionated radiotherapy in localised prostate cancer
by: Nora Sundahl, et al.
Published: (2024-07-01)

A Study on Dosimetric Outcomes and Acute Toxicity of Post Mastectomy Adjuvant Hypofractionated Radiotherapy for Breast Cancer
by: Shivaprasad Deshmukh, et al.
Published: (2016-07-01)

Moderate hypofractionation in prostate cancer: experience from Regional Hospital ISSSTE, Morelos
by: Felipe de J. Tallabs-Villafaña, et al.
Published: (2023-01-01)

MODERATE HYPOFRACTIONATION RADIATION THERAPY IN ESOPHAGEAL CANCER
by: Mahwish Akhter, et al.
Published: (2019-04-01)

Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study
by: F. Sinzabakira, et al.
Published: (2024-09-01)

Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
by: Gabriela S.M. de Siqueira, et al.
Published: (2022-10-01)

Ultra-Hypofractionation for Whole-Breast Irradiation in Early Breast Cancer: Interim Analysis of a Prospective Study
by: Valeria Sigaudi, et al.
Published: (2022-10-01)

Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Hypofractionation: The standard for external beam breast irradiation
by: Adrian Murray Brunt, et al.
Published: (2023-06-01)

Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond
by: Febin Antony, et al.
Published: (2024-01-01)

Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
by: Janice Ser Huey Tan, et al.
Published: (2024-02-01)

Hypofractionation and Concomitant Boost in Ductal Carcinoma In Situ (DCIS): Analysis of a Prospective Case Series with Long-Term Follow-Up
by: Domenico Cante, et al.
Published: (2022-06-01)

EFFICACY OF HYPOFRACTIONATED ADJUVANT RADIATION THERAPY IN PATIENTS WITH OPERABLE BREAST CANCER
by: G. V. Afonin, et al.
Published: (2018-11-01)

Normal tissue complications following hypofractionated chest wall radiotherapy in breast cancer patients and their correlation with patient, tumor, and treatment characteristics
by: Mohsin Khan, et al.
Published: (2017-01-01)

Effect of hypofractionated radiotherapy on lung functions in breast cancer patients
by: Enass A.A. Rezk, et al.
Published: (2023-01-01)

Automated Hypofractionated IMRT treatment planning for early-stage breast Cancer
by: Ting-Chun Lin, et al.
Published: (2020-03-01)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
by: Boram Ha, et al.
Published: (2019-01-01)

Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes
by: Cuccia F, et al.
Published: (2018-10-01)

Hypofractionated Radiotherapy for Prostate Cancer: A Comparative Study of Clinical Outcomes and Dosimetry Between Proton and Photon Therapy
by: Wu CT, et al.
Published: (2025-10-01)

Hypofractionated versus conventional radiotherapy for head-and-neck cancer: A systematic review and meta-analysis
by: Arnab Roy, et al.
Published: (2025-01-01)

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity
by: Kaicheng Pan, et al.
Published: (2024-07-01)

Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer
by: G. V. Afonin, et al.
Published: (2018-08-01)

Incidence of acute radiodermatitis in women with breast cancer undergoing hypofractionated radiotherapy
by: Laura Beatriz Sousa de Jesus Martelletti, et al.
Published: (2021-09-01)

Cost Minimization Analysis of Hypofractionated Radiotherapy
by: Hannah L. Yaremko, et al.
Published: (2021-01-01)

Hypofractionation in postmastectomy breast irradiation. How safe are we in using standard tangentials?
by: Bindhu Joseph, et al.
Published: (2017-07-01)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
by: Ioannis M. Koukourakis, et al.
Published: (2021-09-01)

High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer
by: Ono Takashi, et al.
Published: (2017-06-01)

Randomized Prospective Study Comparing Conventional Versus Hypofractionated Adjuvant Radiotherapy in Node-Positive Breast Cancer
by: Mai Atef, et al.
Published: (2019-12-01)

Once-weekly ultra-hypofractionated radiation therapy for breast cancer: Outcomes from a single-institution real-world cohort
by: María Jesús García Anaya, et al.
Published: (2025-12-01)

Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma
by: Ellery Koelker-Wolfe, et al.
Published: (2025-02-01)

Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
by: Lorein Gonzalez, et al.
Published: (2024-10-01)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
by: Christoph Oehler, et al.
Published: (2022-08-01)

Assessment of Arm Lymphedema After Once-weekly Hypofractionated Radiotherapy for Breast Cancer Patients in Qena University Hospital
by: Alaa A. Hassan, et al.
Published: (2025-01-01)

A Biological-Driven Approach to Explore Dose-Escalated Ultra-Hypofractionation in Breast Cancer Radiotherapy
by: Marco Calvaruso, et al.
Published: (2025-09-01)

Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
by: Sen-Quan Feng, et al.
Published: (2023-07-01)

SHORT-TERM OUTCOMES OF CHEMORADIOTHERAPY USING ACCELERATED HYPOFRACTIONATION FOR THE TREATMENT OF CANCER OF THE OROPHARYNGEAL MUCOSA
by: M. U. Radzhapova, et al.
Published: (2017-12-01)